Melanoma is a fast-progressing skin cancer characterized by a high mortality rate after metastasis. Local chemotherapy could ...
AZoNano on MSN1d
New Adhesive Patch for Drug DeliveryA study reveals a novel adhesive patch prototype using AgNP-Cx+ for enhanced anti-tumor activity against melanoma, showcasing ...
Monopar Therapeutics Inc.’s MNPR share price has surged by 10.22%, which has investors questioning if this is right time to sell.
Melanoma is a fast-progressing skin cancer characterized by a high mortality rate after metastasis. Local chemotherapy could ...
Supporters of devoted sarcoma awareness campaigner Darell McDonald say he leaves a powerful legacy following his death at 44 ...
A doctor at a local cancer institute hopes to do more clinical studies to see if lab findings apply to actual patients. Read more at straitstimes.com.
The clinical utility of the cancer chemotherapeutic agent doxorubicin (DOX) is limited by its cardiotoxicity. Doxorubicinol (DOXol), the major biometabolite of DOX, preferentially accumulates in ...
Stockhead on MSN5d
ASX Quarterly Health Wrap: Blinklab starts key FDA study, Mach 7 set to meet FY25 guidanceFY25 Blinklab initiated an FDA registrational study of its Dx 1 platform as an aid in autism diagnosis, plus more biotech ...
ALX Oncology Holdings Inc.’s ALXO share price has surged by 11.88%, which has investors questioning if this is right time to ...
Ann LaCasce, MD, MMSc, delved into some of the most recent advances in the lymphoma space, exploring how these new therapies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback